Cynical post. Thymosin beta-4 (TB-500) has a fan base and a sceptic base and both are reading the same four papers differently.
Loose evidence is not the same as no evidence and people overcorrect in both directions.
The comparison group matters more than the compound when the outcome is something as fuzzy as focus.
What surprised me is how much of the perceived benefit was routine and attention rather than pharmacology.
Two weeks is not enough time to attribute anything to a compound unless the effect is dramatic.
How do you separate the compound effect from the routine around it?
Loose evidence is not nothing, but a washout either side is the only reason to trust your own take. Not on TB-500 but the pattern is familiar.
Where does the human data stop and the extrapolation begin? That is the whole thread.
I would take the narrow conclusion. Broad ones are more interesting and less true. A year in on TB-500 and it lines up.
Is a baseline blood test really necessary before starting something like this?
Sterility is the part people wave through and it is the part that actually bites.
Sterility is the part people wave through and it is the part that actually bites.
How long before you can reasonably say something is or is not doing anything?
Same here.
Baseline first. How long have you been on TB-500?
Underdosing and tolerance are indistinguishable from the inside, and everyone picks the flattering explanation.
Stupid question: how do you know whether what is in the vial matches the label at all?
What is the first thing you would read if you were starting from zero? Fatigue was my main issue with TB-500 too.
Most of the popular protocol is borrowed from a clinical population and applied to healthy people without comment.
Narrow conclusion.